Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Peripheral Blood (PB) CD34+ Cell Counts Obtained On Day 1 of Apheresis Predict Poor Mobilization for Autologous Peripheral Hematopoietic Progenitor Cell (HPC) Transplantation

Peripheral Blood (PB) CD34+ Cell Counts Obtained On Day 1 of Apheresis Predict Poor Mobilization for Autologous Peripheral Hematopoietic Progenitor Cell (HPC) Transplantation. 9th Annual ISCT Meeting Final Program. 2003; 49.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.